Kymab Competitors and Similar CompaniesClear all
Kymab's competitors and similar companies include enVVeno and QGel.
 Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. |  enVVeno Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). |  QGel QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics. | |
Founding Date | Founding Date 2009 | Founding Date 1987 | Founding Date 2009 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, GB HQ | Locations Irvine, US HQ | Locations Lausanne, CH HQ |
Employees | Employees 407% decrease | Employees 1525% increase | Employees 147% decrease |
Funding | |||
Latest funding round | Latest funding round $ 100m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 12m (over 9 years ago) |
Total funding raised | Total funding raised $ 220.4m | Total funding raised N/A | Total funding raised $ 12m |
For sources of this data, please see the company profile
View Company Profiles
enVVeno
HQ
Irvine, US
Employees
15↑ 25% increase
Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
View companyQGel
HQ
Lausanne, CH
Employees
14↓ 7% decrease
QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics.
View company